Technical Analysis for ACST - Acasti Pharma, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| See historical ACST trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jun 22 | 50 DMA Resistance | Bearish | 0.00% |
| Jun 22 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% |
| Jun 22 | Upper Bollinger Band Touch | Strength | 0.00% |
| Jun 21 | Calm After Storm | Range Contraction | -4.00% |
| Jun 20 | Calm After Storm | Range Contraction | 1.41% |
| Jun 19 | Down 3 Days in a Row | Weakness | 8.27% |
| Jun 15 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 1.41% |
| Jun 15 | Inside Day | Range Contraction | 1.41% |
| Jun 14 | 50 DMA Resistance | Bearish | -10.00% |
| Jun 14 | Volume Surge | Other | -10.00% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2017-10-10
- Sector: Healthcare
- Industry: Pharmaceuticals
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more ACST news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 3.36 |
| 52 Week Low | 0.6 |
| Average Volume | 259,361 |
| 200-Day Moving Average | 1.1078 |
| 50-Day Moving Average | 0.7605 |
| 20-Day Moving Average | 0.6984 |
| 10-Day Moving Average | 0.7034 |
| Average True Range | 0.0537 |
| ADX | 24.52 |
| +DI | 28.0 |
| -DI | 10.67 |
| Chandelier Exit (Long, 3 ATRs ) | 0.6589 |
| Chandelier Exit (Short, 3 ATRs ) | 0.8111 |
| Upper Bollinger Band | 0.7608 |
| Lower Bollinger Band | 0.636 |
| Percent B (%b) | 0.67 |
| BandWidth | 17.869416 |
| MACD Line | -0.0105 |
| MACD Signal Line | -0.0202 |
| MACD Histogram | 0.0097 |
| Fundamentals | Value |
|---|---|
| Market Cap | 10.59 Million |
| Num Shares | 14.7 Million |
| EPS | -0.77 |
| Price-to-Earnings (P/E) Ratio | -0.94 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 1.22 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.83 | ||||
| Resistance 3 (R3) | 0.83 | 0.80 | 0.81 | ||
| Resistance 2 (R2) | 0.80 | 0.77 | 0.80 | 0.80 | |
| Resistance 1 (R1) | 0.76 | 0.76 | 0.75 | 0.76 | 0.80 |
| Pivot Point | 0.73 | 0.73 | 0.72 | 0.73 | 0.73 |
| Support 1 (S1) | 0.69 | 0.70 | 0.68 | 0.69 | 0.64 |
| Support 2 (S2) | 0.66 | 0.69 | 0.66 | 0.64 | |
| Support 3 (S3) | 0.62 | 0.66 | 0.63 | ||
| Support 4 (S4) | 0.62 |
